Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00692692 · ClinicalTrials.gov registry record · NA
Use of Dermal Matrix in Breast Reconstruction
A NA study, sponsored by Vanderbilt University.
- Terminated
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT00692692: Clinical Trial NA study, sponsored by Vanderbilt University.
NCT00692692 is a NA study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00692692, a NA study, was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
We propose to evaluate the question of whether there is a significant difference between the traditional method of serratus flap tissue expander reconstruction and the acellular matrix method.
Interventions
- PROCEDURE DermaMatrix
- PROCEDURE standard of care tissue expander breast reconstruction surgery after mastectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2007-06 |
| Est. Completion | 2010-12 |
| Phase | NA |
Why NCT00692692 stopped before completion
NCT00692692 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which DermaMatrix is the first listed.
NCT00692692 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00692692 about?
NCT00692692 is a clinical study titled "Use of Dermal Matrix in Breast Reconstruction". We propose to evaluate the question of whether there is a significant difference between the traditional method of serratus flap tissue expander reconstruction and the acellular matrix method.
What is the current status of trial NCT00692692?
This trial is currently terminated. It is a NA study. The enrollment target is 36 participants. The study started on 2007-06. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00692692?
The interventions under investigation include: DermaMatrix (PROCEDURE), standard of care tissue expander breast reconstruction surgery after mastectomy (PROCEDURE).
Who is sponsoring clinical trial NCT00692692?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00692692's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia